Aspergillosis: nosocomial or community-acquired?

Marie-Christine Nicolle1, Thomas Benet, Philippe Vanhems

  • 1Service d'Hygiène Hospitalière, Epidémiologie et Prévention, Hôpital Edouard Herriot, Hospices Civils de Lyon, 5 place d'Arsonval, Lyon, France.

Medical Mycology
|September 8, 2010
PubMed

Insights

Distinguishing hospital-acquired infections from community infections is crucial for prevention. This study highlights challenges in defining nosocomial invasive aspergillosis, impacting patient outcomes.

Area of Science:

  • Infectious Diseases
  • Hospital Epidemiology
  • Mycology

Background:

  • Differentiating nosocomial infections (NI) from community-acquired infections is vital for effective control strategies.
  • Nosocomial infections are acquired during hospitalization and require specific hospital-based interventions.
  • Accurate classification of infections aids in targeted prevention and treatment protocols.

Purpose of the Study:

  • To explore the difficulties in defining and diagnosing nosocomial invasive aspergillosis (IA).
  • To examine the challenges posed by IA's variable incubation period and potential sources.
  • To discuss the contribution of hospital versus community factors in IA development.

Main Methods:

  • Review of epidemiological and microbiological criteria for defining nosocomial infections.
  • Analysis of factors influencing invasive aspergillosis incubation periods.
  • Discussion of causality criteria for hospital-acquired versus community-acquired determinants.

Main Results:

  • Standard definitions of NI are challenging to apply to invasive aspergillosis (IA).
  • Identifying the source of IA (hospital vs. community) is often difficult.
  • Lack of consistent data on IA incubation periods complicates diagnosis and attribution.

Conclusions:

  • Defining nosocomial invasive aspergillosis presents significant challenges.
  • Understanding early IA events is critical for developing effective prevention strategies.
  • Improved diagnostic and epidemiological approaches are needed for IA management.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...